Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Admicom Oyj ADMCM Oct 23, 2019 53.20 -0.37   
 Afarak Group AFAGR Oct 23, 2019 0.60 +1.88   
 Ahlstrom-Munksjö AM1 Oct 23, 2019 14.16 -0.70   
 Ahlstrom-Munksjö AM1S Oct 23, 2019 152.00 -0.52   
 Ahola Transport AHOLA Oct 23, 2019 0.74 -9.76   
 Aktia Bank AKTIA Oct 23, 2019 8.54 +0.12   
 Alma Media ALMA Oct 23, 2019 6.90 0.00   
 Altia ALTIA Oct 23, 2019 7.86 +0.38   
 Apetit APETIT Oct 23, 2019 7.74 -0.77   
 Asiakastieto Group ATG1V Oct 23, 2019 28.50 +0.35   
 Aspo ASPO Oct 23, 2019 8.70 0.00   
 Aspocomp Group ACG1V Oct 23, 2019 6.26 -6.85   
 Atria A ATRAV Oct 23, 2019 7.92 +6.59   
 Basware BAS1V Oct 23, 2019 20.20 +0.50   
 BBS-Bioactive Bone Substitutes BONEH Oct 23, 2019 2.38 +0.85   
 Biohit B BIOBV Oct 23, 2019 2.93 -1.01   
 Bittium BITTI Oct 23, 2019 6.21 -0.96   
 CapMan CAPMAN Oct 23, 2019 1.94 0.00   
 Cargotec CGCBV Oct 23, 2019 28.60 -3.38   
 Caverion CAV1V Oct 23, 2019 5.60 -0.89   
 Citycon CTY1S Oct 23, 2019 9.64 +0.05   
 Componenta CTH1V Oct 23, 2019 0.13 -2.31   
 Consti Yhtiöt CONSTI Oct 23, 2019 4.90 +0.41   
 Cramo CRA1V Oct 23, 2019 9.50 -1.76   
 Detection Technology DETEC Oct 23, 2019 20.90 +2.45   
 Digia DIGIA Oct 23, 2019 3.66 +0.55   
 Digitalist Group DIGIGR Oct 23, 2019 0.05 0.00   
 DNA DNA Oct 23, 2019 20.86 -0.19   
 Dovre Group DOV1V Oct 23, 2019 0.23 0.00   
 EAB Group EAB Oct 23, 2019 2.84 +0.71   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK